Recon: EMA recommends Regeneron, Celltrion antibodies; Ellume test recall expanded to 2M units
ReconMichael MezherBiologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy